Regeneron Pharma (REGN) PT Raised to $925 at Barclays
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $808.34 +0.60%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Barclays analyst Carter Gould raised the price target on Regeneron Pharma (NASDAQ: REGN) to $925.00 (from $900.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group
- Shimao Property Holdings Limited (813:HK) (SIOPF) PT Lowered to HK$0.05 at JPMorgan
- JD Logistics Inc (2618:HK) (JDLGF) PT Lowered to HK$18 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
